Drug Shortage Report for SODIUM ACETATE INJECTION, USP
Report ID | 168505 |
Drug Identification Number | 02139529 |
Brand name | SODIUM ACETATE INJECTION, USP |
Common or Proper name | SODIUM ACETATE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM ACETATE |
Strength(s) | 328MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-09-02 |
Company comments | Long term supply status is currently unknown; however, we assure you we are working diligently with our plants for resolution and updates can be expected in the weeks ahead. We strongly encourage all customers to use prudent conservation measures to extend the supply as long as possible. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-09-02 | English | Compare |
v2 | 2022-09-01 | French | Compare |
v1 | 2022-09-01 | English | Compare |
Showing 1 to 3 of 3